Search results for " farmacoterapia"

showing 9 items of 9 documents

Tratamiento médico - psiquiátrico de los trastornos de personalidad en adictos

2007

El tratamiento médico de los trastornos de la personalidad en adictos suele ser un ineludible complemento para la viabilidad de la intervención psico y socioterapéutica. En no pocas ocasiones una certera farmacoterapia es definitiva para el éxito terapéutico.Mediante un doble estudio cualitativo y cuantitativo, se exponen las claves del acierto prescriptivo. Se efectuó una revisión de 260 historias de pacientes tratados psicofarmacológicamente y filiados en la clasificación CIE-10 como trastorno por uso de sustancias con trastorno psíquico y/o de la personalidad asociado. Para el estudio cualitativo se celebraron sucesivas reuniones de equipos mixtos (médico, psiquiatra, ATS y psicólogos) a…

:PSICOLOGÍA::Psicofarmacología [UNESCO]:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍAAdicción. Drogodependencia. Trastorno de personalidad. Sociopatía. Caracteropatía. Tratamiento psicofarmacológico. Tratamiento psiquiátrico. Intervención. Tratamiento. Farmacoterapia.UNESCO::PSICOLOGÍA::Psicofarmacología
researchProduct

Documento de consenso de la Sociedad Española de Arteriosclerosis (SEA) para la prevención y tratamiento de la enfermedad cardiovascular en la diabet…

2018

Este artículo se encuentra disponible en la siguiente URL: https://www.elsevier.es/es-revista-clinica-e-investigacion-arteriosclerosis-15-articulo-documento-consenso-sociedad-espanola-arteriosclerosis-S0214916818300846 This is the pre-peer reviewed version of the following article: Ruiz-García, A., Arranz-Martínez, E., Morón-Merchante, I., Pascual-Fuster, V., Tamarit, JJ., Trias-Villagut, F. et al. (2018). Documento de consenso de la Sociedad Española de Arteriosclerosis (SEA) para la prevención y tratamiento de la enfermedad cardiovascular en la diabetes mellitus tipo 2. Clínica e Investigación en Arteriosclerosis, vol. 30, supl. 1 (julio), pp. 1-19, which has been published in final form …

Blood pressure controlmedicine.medical_specialtyHipertensión.FarmacologíaEnfermedad cardiovascularDisease030204 cardiovascular system & hematologyDiabetes - Farmacoterapia.Enfermedades cardiovasculares - Factores de riesgo - Tratamiento.Diabetes - Chemotherapy.03 medical and health sciencesTratamiento médicoCardiovascular system - Diseases - Risk factors - Treatment.0302 clinical medicineDiabetes mellitusHypertension.MedicinePharmacology (medical)Lipid controlHypoglycemic drugs030212 general & internal medicineIntensive care medicineInhibidores de agregación plaquetariabusiness.industryHypertriglyceridemiaType 2 Diabetes Mellitusnutritional and metabolic diseasesArteriosclerosismedicine.diseaseDiabetes mellitus tipo 2Cardiology and Cardiovascular Medicinebusiness
researchProduct

Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice.

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190540 También participan en la elaboración de este artículo científico: Aracely Calatayud-Pascual, Alicia López-Castellano, Elena P. Albelda, Enrique García-España, Luis Martí-Bonmatí, Juan C. Frias y M. Teresa Albelda. Fumagillin-loaded liposomes were injected into ApoE-KO mice. The animals were divided into several groups to test the efficacy of this anti-angiogenic drug for early treatment of atherosclerotic lesions. Statistical analysis of the lesions revealed a decrease in the lesion size after 5 weeks of treatment.

Fluorescence-lifetime imaging microscopyPathologylcsh:MedicineAngiogenesis Inhibitors02 engineering and technology030204 cardiovascular system & hematologyVascular MedicineBiochemistryArteriosclerosis - Chemotherapy.Diagnostic RadiologyAteroesclerosis - Farmacoterapia.MiceWhite Blood Cells0302 clinical medicineAnimal CellsArteriosclerosis - Farmacoterapia.Medicine and Health SciencesArteries - Diseases - Treatment.Nanotechnologylcsh:ScienceAortaPhospholipidsmedia_commonMice KnockoutLiposomeDrug CarriersMultidisciplinarymedicine.diagnostic_testRadiology and Imaging021001 nanoscience & nanotechnologyMagnetic Resonance ImagingLipidsFatty Acids UnsaturatedEngineering and Technologymedicine.symptomCellular Structures and OrganellesCellular TypesAnatomy0210 nano-technologySesquiterpenesResearch ArticleDrugmedicine.medical_specialtyImaging Techniquesmedia_common.quotation_subjectImmune CellsImmunologyLiposomes.Research and Analysis MethodsLiposomas.Lesion03 medical and health sciencesText miningApolipoproteins ECyclohexanesDiagnostic Medicinemedicine.arteryFluorescence ImagingmedicineAnimalsArterias - Enfermedades - Tratamiento.VesiclesAortaBlood Cellsbusiness.industryMacrophageslcsh:RAnti angiogenicBiology and Life SciencesMagnetic resonance imagingCell BiologyAtherosclerosisFumagillin - Therapeutic use.Atherosclerosis - Chemotherapy.Disease Models AnimalFumagilina - Uso terapéutico.LiposomesCardiovascular AnatomyNanoparticlesBlood Vesselslcsh:QbusinessPloS one
researchProduct

The debate on rare diseases : a look at media response

2015

Este artículo se encuentra disponible en la siguiente URL: https://ojs.uv.es/index.php/Metode/article/view/7188/7809 Este monográfico lleva por título "Science grid : the public understanding of science". Rare diseases (RDs) are those that affect fewer than five people in every 10,000. There are around 7,000 RDs, they are difficult to diagnose and very few have a treatment. This article explores how the media report on the arguments and counter-arguments regarding the access to drugs for these pathologies, with critical discourse analysis for the case of Duchenne muscular dystrophy. We concluded that, in times of crisis, the debate polarises around economic arguments (the price of drugs), r…

Medios de comunicación social.MultidisciplinaryHistory and Philosophy of ScienceMass media.Medicamentos - Crítica y objeción.Enfermedades raras - Discursos políticos.Duchenne Muscular Distrophy - Chemotherapy.Rare diseases - Political speeches.Duchenne Distrofia muscular de - Farmacoterapia.Drugs - Criticism and objection.humanitieshealth care economics and organizations
researchProduct

Biological Profiling of Semisynthetic C19-Functionalized Ferruginol and Sugiol Analogues

2021

[EN] The abietane-type diterpenoids are significant bioactive compounds exhibiting a varied range of pharmacological properties. In this study, the first synthesis and biological investigation of the new abietane-diterpenoid (+)-4-epi-liquiditerpenoid acid (8a) together with several of its analogs are reported. The compounds were generated from the readily available methyl callitrisate (7), which was obtained from callitrisic acid present in Moroccan Sandarac resin. A biological evaluation was conducted to determine the effects of the different functional groups present in these molecules, providing basic structure-activity relationship (SAR) elements. In particular, the ferruginol and sugi…

Microbiology (medical)Pharmacology.KetoneStereochemistryCarboxylic acidFarmacología.Antiproliferative activity01 natural sciencesBiochemistryMicrobiologyArticleAntimalarial activityHeLachemistry.chemical_compoundDiterpenoidMoiety03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsAbietanechemistry.chemical_classificationMalaria - Chemotherapy.biology010405 organic chemistryChemistrylcsh:RM1-950Sandaracbiology.organism_classificationGABA<sub>A</sub> receptor modulatorsTerpenoidCallitrisic acid0104 chemical sciencesFerruginol010404 medicinal & biomolecular chemistrylcsh:Therapeutics. PharmacologyInfectious DiseasesPaludismo - Farmacoterapia.AbietaneGABAA receptor modulators
researchProduct

1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00054/full En este artículo científico participan los siguientes autores: Mario Amore, Guido Di Sciascio, Radu Ioan Florea, Marina Garriga, Gabriel Gonzalez, Kai G. Kahl, Per-Axel Karlsson, Jens Kuhn, Maria Margariti, Bruno Pacciardi, Konstantinos Papageorgiou, Maurizio Pompili, Fabrice Rivollier, Ángel Royuela, Gemma Safont, Joachim Scharfetter, Bo Skagen, Kazuhiro Tajima-Pozo y Pierre Vidailhet. Agitation is a heterogeneous concept without a uniformly accepted definition, however, it is generally considered as a state of cognitive and motor hype…

Schizophrenia - Treatment.Psychomotor agitationlcsh:RC435-571media_common.quotation_subjectPsychomotor disorders - Treatment.ReviewMotor HyperactivityPsicosis maníaco depresiva - Tratamiento.Esquizofrenia - Farmacoterapia.Psicomotricidad - Trastornos - Tratamiento.03 medical and health sciences0302 clinical medicinePromotion (rank)Bipolar disorder Clinical practice Management Psychomotor agitation Schizophrenia Psychiatry and Mental HealthNursinglcsh:Psychiatrymedicinebipolar disorder; clinical practice; management; psychomotor agitation; schizophreniaManic-depressive illness030212 general & internal medicineManic-Depressive illness - Treatment.media_commonPsychiatrybipolar disorderProtocol (science)Psicosis maníaco depresiva - Farmacoterapia.Trastorn bipolarHealth professionalsCognitionManic-Depressive illnes - Chemotherapy.clinical practice030227 psychiatryschizophreniaClinical PracticeSchizophrenia - Chemotherapy.Psychiatry and Mental healthpsychomotor agitationSchizophreniaEsquizofrèniaEsquizofrenia - Tratamiento.medicine.symptomEmotional arousalPsychologymanagement
researchProduct

L'approccio integrato antipsicotici-psicoterapia nel trattamento del disturbo Borderline di personalità

2009

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.disturbo di personalità borderline psicoterapia farmacoterapiaSettore MED/25 - Psichiatria
researchProduct

La valutazione del grado di insight in pazienti schizofrenici in trattamento con antipsicotici atipici inseriti in un gruppo riabilitativo

2010

insight farmacoterapia aderenza
researchProduct

Analysis of the molecular mechanisms that mediate the therapeutic actions of glucocorticoids in skin

2017

Tesis doctoral 189 páginas, 53 figuras, 1 tabla como material suplementario

skinPiel -- Enfermedades -- FarmacoterapiaUNESCO::CIENCIAS DE LA VIDAglucocorticoid receptorGlucocorticoides -- Uso terapeúticokeratinocytegilzzfp36klf4mouse:CIENCIAS DE LA VIDA [UNESCO]
researchProduct